ResMed Inc. (LON:0KW4)
London · Delayed Price · Currency is GBP · Price in USD 244.56
+2.19 (0.90%)
Dec 19, 2025, 3:24 PM BST
ResMed Market Cap
ResMed has a market cap or net worth of 26.69 billion as of December 19, 2025. Its market cap has decreased by -5.98% in one year.
Market Cap
26.69B
Enterprise Value
26.29B
Revenue
3.91B
Ranking
n/a
PE Ratio
24.95
Stock Price
244.56
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 24.33M to 26.69B, an increase of 109,601.00%. That is a compound annual growth rate of 25.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 26.69B | -0.49% |
| Dec 31, 2024 | 26.82B | 35.04% |
| Dec 29, 2023 | 19.86B | -21.72% |
| Dec 30, 2022 | 25.37B | -9.78% |
| Dec 31, 2021 | 28.12B | 24.65% |
| Dec 31, 2020 | 22.56B | 34.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| GSK plc | 73.11B |
| Haleon | 33.29B |
| Smith & Nephew | 10.48B |
| Convatec Group | 4.72B |
| Hikma Pharmaceuticals | 3.35B |
| HUTCHMED (China) | 1.71B |
| Genus | 1.71B |